The VHL tumor suppressor gene was initially discovered as a germline mutation in patients at risk for clear cell renal cell carcinoma (ccRCC), which constitutes approximately 85% of all kidney cancers (3). Here, VHL is linked to nonpapillary renal cell carcinoma.